Feb 25, 2026 | Articles, GLP-1, Menopause, Peptide Therapy
Menopause is one of the biggest physiological transitions a woman will ever experience, yet most feel unprepared for how dramatically it affects energy, weight, mood, sleep, metabolism, and overall health. Some changes show up slowly. Others hit without warning. Many...
Feb 25, 2026 | Articles, GLP-1
GLP-1 medications work. That’s not the problem. The problem is muscle loss when weight loss isn’t properly supported. This guide explains: Why muscle loss happens on GLP-1s How to prevent it Protein targets that matter Training strategies that work The role of...
Feb 18, 2026 | GLP-1, Peptide Therapy, Weight Loss
Dining out with friends, family, or colleagues can be a challenge when you’re following a peptide-based weight loss protocol or using peptides for hormone optimization. Many peptides, particularly those used in weight loss and hormone therapy, can suppress...
Feb 18, 2026 | Articles, GLP-1, Peptide Therapy
Peptide therapies, particularly those like GLP-1 agonists (e.g., Ozempic), have become a popular solution for weight loss, improved insulin sensitivity, and overall metabolic health. However, despite their benefits, many people undergoing peptide therapy report...
Feb 18, 2026 | Articles, GLP-1, Peptide Therapy
Quick Summary: To prevent sarcopenia (muscle loss) during GLP-1 therapy (Semaglutide/Tirzepatide), patients must prioritize a “Protein-First” diet of 1.2–1.6g/kg of body weight, engage in resistance training at least twice weekly, and consider supportive...
Feb 18, 2026 | GLP-1, Peptide Therapy
Retatrutide is one of the most aggressive obesity drugs ever tested in clinical trials. In a Phase 2 study, people with obesity lost more than 24% of their starting body weight in under a year at higher doses, a level of weight loss that rivals bariatric surgery...
